nodes	percent_of_prediction	percent_of_DWPC	metapath
Pamidronate—FDPS—Cholesterol Biosynthesis—HMGCR—atherosclerosis	0.0276	0.114	CbGpPWpGaD
Pamidronate—FDPS—Cholesterol biosynthesis—HMGCR—atherosclerosis	0.0203	0.0836	CbGpPWpGaD
Pamidronate—FDPS—Activation of gene expression by SREBF (SREBP)—HMGCR—atherosclerosis	0.0126	0.0518	CbGpPWpGaD
Pamidronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—HMGCR—atherosclerosis	0.01	0.0414	CbGpPWpGaD
Pamidronate—Histamine Phosphate—HRH1—atherosclerosis	0.00953	0.56	CrCbGaD
Pamidronate—FDPS—SREBP signalling—LDLR—atherosclerosis	0.00921	0.0379	CbGpPWpGaD
Pamidronate—FDPS—SREBP signalling—SCARB1—atherosclerosis	0.00861	0.0355	CbGpPWpGaD
Pamidronate—FDPS—SREBP signalling—HMGCR—atherosclerosis	0.00813	0.0335	CbGpPWpGaD
Pamidronate—FDPS—Activation of gene expression by SREBF (SREBP)—PPARA—atherosclerosis	0.00777	0.032	CbGpPWpGaD
Pamidronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—PPARA—atherosclerosis	0.00621	0.0255	CbGpPWpGaD
Pamidronate—FDPS—SREBP signalling—SIRT1—atherosclerosis	0.00605	0.0249	CbGpPWpGaD
Pamidronate—FDPS—SREBP signalling—LPL—atherosclerosis	0.00569	0.0234	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.00444	0.0183	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.00418	0.0172	CbGpPWpGaD
Pamidronate—FDPS—SREBP signalling—PPARG—atherosclerosis	0.00415	0.0171	CbGpPWpGaD
Pamidronate—FDPS—SREBP signalling—INS—atherosclerosis	0.00407	0.0168	CbGpPWpGaD
Pamidronate—Risedronate—PTGS2—atherosclerosis	0.00396	0.233	CrCbGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.00362	0.0149	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.00362	0.0149	CbGpPWpGaD
Pamidronate—Clodronate—PTGS2—atherosclerosis	0.00353	0.207	CrCbGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.00286	0.0118	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.00269	0.0111	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.00269	0.0111	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.00264	0.0109	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.0026	0.0107	CbGpPWpGaD
Pamidronate—Arthralgia—Rosuvastatin—atherosclerosis	0.00254	0.00344	CcSEcCtD
Pamidronate—Myalgia—Rosuvastatin—atherosclerosis	0.00254	0.00344	CcSEcCtD
Pamidronate—Flushing—Simvastatin—atherosclerosis	0.00253	0.00341	CcSEcCtD
Pamidronate—Alopecia—Ezetimibe—atherosclerosis	0.00252	0.00341	CcSEcCtD
Pamidronate—Haemoglobin—Niacin—atherosclerosis	0.00251	0.00339	CcSEcCtD
Pamidronate—Rhinitis—Niacin—atherosclerosis	0.0025	0.00338	CcSEcCtD
Pamidronate—Haemorrhage—Niacin—atherosclerosis	0.0025	0.00338	CcSEcCtD
Pamidronate—Erythema—Ezetimibe—atherosclerosis	0.00248	0.00336	CcSEcCtD
Pamidronate—Malnutrition—Ezetimibe—atherosclerosis	0.00248	0.00336	CcSEcCtD
Pamidronate—Dysgeusia—Lovastatin—atherosclerosis	0.00248	0.00335	CcSEcCtD
Pamidronate—Rhinitis—Pravastatin—atherosclerosis	0.00247	0.00333	CcSEcCtD
Pamidronate—Confusional state—Rosuvastatin—atherosclerosis	0.00246	0.00332	CcSEcCtD
Pamidronate—Back pain—Lovastatin—atherosclerosis	0.00245	0.00331	CcSEcCtD
Pamidronate—Chills—Simvastatin—atherosclerosis	0.00244	0.0033	CcSEcCtD
Pamidronate—Muscle spasms—Lovastatin—atherosclerosis	0.00243	0.00329	CcSEcCtD
Pamidronate—Infection—Rosuvastatin—atherosclerosis	0.00242	0.00327	CcSEcCtD
Pamidronate—Alopecia—Simvastatin—atherosclerosis	0.0024	0.00325	CcSEcCtD
Pamidronate—Back pain—Ezetimibe—atherosclerosis	0.0024	0.00325	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.0024	0.00988	CbGpPWpGaD
Pamidronate—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00239	0.00323	CcSEcCtD
Pamidronate—Muscle spasms—Ezetimibe—atherosclerosis	0.00239	0.00323	CcSEcCtD
Pamidronate—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00239	0.00323	CcSEcCtD
Pamidronate—Erythema—Simvastatin—atherosclerosis	0.00237	0.0032	CcSEcCtD
Pamidronate—Ill-defined disorder—Lovastatin—atherosclerosis	0.00235	0.00318	CcSEcCtD
Pamidronate—Eye disorder—Niacin—atherosclerosis	0.00233	0.00316	CcSEcCtD
Pamidronate—Dysgeusia—Simvastatin—atherosclerosis	0.00232	0.00313	CcSEcCtD
Pamidronate—Flushing—Niacin—atherosclerosis	0.00232	0.00313	CcSEcCtD
Pamidronate—Angioedema—Lovastatin—atherosclerosis	0.00231	0.00313	CcSEcCtD
Pamidronate—Ill-defined disorder—Ezetimibe—atherosclerosis	0.0023	0.00311	CcSEcCtD
Pamidronate—Anaemia—Ezetimibe—atherosclerosis	0.0023	0.0031	CcSEcCtD
Pamidronate—Malaise—Lovastatin—atherosclerosis	0.00228	0.00309	CcSEcCtD
Pamidronate—Flushing—Pravastatin—atherosclerosis	0.00228	0.00309	CcSEcCtD
Pamidronate—Cardiac disorder—Pravastatin—atherosclerosis	0.00228	0.00309	CcSEcCtD
Pamidronate—Muscle spasms—Simvastatin—atherosclerosis	0.00228	0.00308	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.00227	0.00936	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.00227	0.00936	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.00227	0.00936	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.00227	0.00936	CbGpPWpGaD
Pamidronate—Angioedema—Ezetimibe—atherosclerosis	0.00227	0.00307	CcSEcCtD
Pamidronate—Angiopathy—Niacin—atherosclerosis	0.00227	0.00306	CcSEcCtD
Pamidronate—Leukopenia—Lovastatin—atherosclerosis	0.00227	0.00306	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.00225	0.00925	CbGpPWpGaD
Pamidronate—Chills—Niacin—atherosclerosis	0.00224	0.00303	CcSEcCtD
Pamidronate—Malaise—Ezetimibe—atherosclerosis	0.00224	0.00303	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00222	0.003	CcSEcCtD
Pamidronate—Alopecia—Niacin—atherosclerosis	0.00221	0.00298	CcSEcCtD
Pamidronate—Chills—Pravastatin—atherosclerosis	0.00221	0.00298	CcSEcCtD
Pamidronate—Insomnia—Rosuvastatin—atherosclerosis	0.00221	0.00298	CcSEcCtD
Pamidronate—Ill-defined disorder—Simvastatin—atherosclerosis	0.0022	0.00297	CcSEcCtD
Pamidronate—Paraesthesia—Rosuvastatin—atherosclerosis	0.00219	0.00296	CcSEcCtD
Pamidronate—Anaemia—Simvastatin—atherosclerosis	0.00219	0.00296	CcSEcCtD
Pamidronate—Erythema—Niacin—atherosclerosis	0.00217	0.00294	CcSEcCtD
Pamidronate—Malnutrition—Niacin—atherosclerosis	0.00217	0.00294	CcSEcCtD
Pamidronate—Alopecia—Pravastatin—atherosclerosis	0.00217	0.00294	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.00217	0.00893	CbGpPWpGaD
Pamidronate—Cough—Ezetimibe—atherosclerosis	0.00217	0.00293	CcSEcCtD
Pamidronate—Angioedema—Simvastatin—atherosclerosis	0.00216	0.00292	CcSEcCtD
Pamidronate—Arthralgia—Lovastatin—atherosclerosis	0.00216	0.00291	CcSEcCtD
Pamidronate—Myalgia—Lovastatin—atherosclerosis	0.00216	0.00291	CcSEcCtD
Pamidronate—Anxiety—Lovastatin—atherosclerosis	0.00215	0.0029	CcSEcCtD
Pamidronate—Dyspepsia—Rosuvastatin—atherosclerosis	0.00215	0.0029	CcSEcCtD
Pamidronate—Hypertension—Ezetimibe—atherosclerosis	0.00214	0.0029	CcSEcCtD
Pamidronate—Malaise—Simvastatin—atherosclerosis	0.00214	0.00289	CcSEcCtD
Pamidronate—Tension—Niacin—atherosclerosis	0.00213	0.00288	CcSEcCtD
Pamidronate—Discomfort—Lovastatin—atherosclerosis	0.00213	0.00288	CcSEcCtD
Pamidronate—Leukopenia—Simvastatin—atherosclerosis	0.00212	0.00287	CcSEcCtD
Pamidronate—Myalgia—Ezetimibe—atherosclerosis	0.00211	0.00286	CcSEcCtD
Pamidronate—Arthralgia—Ezetimibe—atherosclerosis	0.00211	0.00286	CcSEcCtD
Pamidronate—Nervousness—Niacin—atherosclerosis	0.00211	0.00285	CcSEcCtD
Pamidronate—Tension—Pravastatin—atherosclerosis	0.0021	0.00284	CcSEcCtD
Pamidronate—Dysgeusia—Pravastatin—atherosclerosis	0.0021	0.00283	CcSEcCtD
Pamidronate—Muscle spasms—Niacin—atherosclerosis	0.00209	0.00283	CcSEcCtD
Pamidronate—Discomfort—Ezetimibe—atherosclerosis	0.00209	0.00282	CcSEcCtD
Pamidronate—Pain—Rosuvastatin—atherosclerosis	0.00209	0.00282	CcSEcCtD
Pamidronate—Constipation—Rosuvastatin—atherosclerosis	0.00209	0.00282	CcSEcCtD
Pamidronate—Confusional state—Lovastatin—atherosclerosis	0.00208	0.00282	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.00208	0.00856	CbGpPWpGaD
Pamidronate—Nervousness—Pravastatin—atherosclerosis	0.00208	0.00281	CcSEcCtD
Pamidronate—Anaphylactic shock—Lovastatin—atherosclerosis	0.00207	0.00279	CcSEcCtD
Pamidronate—Muscle spasms—Pravastatin—atherosclerosis	0.00206	0.00278	CcSEcCtD
Pamidronate—Infection—Lovastatin—atherosclerosis	0.00205	0.00277	CcSEcCtD
Pamidronate—Confusional state—Ezetimibe—atherosclerosis	0.00204	0.00276	CcSEcCtD
Pamidronate—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00203	0.00274	CcSEcCtD
Pamidronate—Thrombocytopenia—Lovastatin—atherosclerosis	0.00202	0.00273	CcSEcCtD
Pamidronate—Myalgia—Simvastatin—atherosclerosis	0.00202	0.00273	CcSEcCtD
Pamidronate—Arthralgia—Simvastatin—atherosclerosis	0.00202	0.00273	CcSEcCtD
Pamidronate—Infection—Ezetimibe—atherosclerosis	0.00201	0.00272	CcSEcCtD
Pamidronate—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00201	0.00272	CcSEcCtD
Pamidronate—Anxiety—Simvastatin—atherosclerosis	0.00201	0.00272	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.002	0.00824	CbGpPWpGaD
Pamidronate—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00199	0.00269	CcSEcCtD
Pamidronate—Discomfort—Simvastatin—atherosclerosis	0.00199	0.00269	CcSEcCtD
Pamidronate—Nervous system disorder—Ezetimibe—atherosclerosis	0.00199	0.00269	CcSEcCtD
Pamidronate—Angioedema—Niacin—atherosclerosis	0.00199	0.00269	CcSEcCtD
Pamidronate—Ill-defined disorder—Pravastatin—atherosclerosis	0.00199	0.00268	CcSEcCtD
Pamidronate—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00198	0.00268	CcSEcCtD
Pamidronate—Anaemia—Pravastatin—atherosclerosis	0.00198	0.00267	CcSEcCtD
Pamidronate—FDPS—Metabolism—LDLRAP1—atherosclerosis	0.00198	0.00815	CbGpPWpGaD
Pamidronate—Anorexia—Lovastatin—atherosclerosis	0.00197	0.00266	CcSEcCtD
Pamidronate—Angioedema—Pravastatin—atherosclerosis	0.00196	0.00264	CcSEcCtD
Pamidronate—Syncope—Niacin—atherosclerosis	0.00195	0.00264	CcSEcCtD
Pamidronate—Confusional state—Simvastatin—atherosclerosis	0.00195	0.00263	CcSEcCtD
Pamidronate—Leukopenia—Niacin—atherosclerosis	0.00195	0.00263	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.00193	0.00796	CbGpPWpGaD
Pamidronate—Oedema—Simvastatin—atherosclerosis	0.00193	0.00261	CcSEcCtD
Pamidronate—Anaphylactic shock—Simvastatin—atherosclerosis	0.00193	0.00261	CcSEcCtD
Pamidronate—Malaise—Pravastatin—atherosclerosis	0.00193	0.00261	CcSEcCtD
Pamidronate—Abdominal pain—Rosuvastatin—atherosclerosis	0.00193	0.00261	CcSEcCtD
Pamidronate—Infection—Simvastatin—atherosclerosis	0.00192	0.0026	CcSEcCtD
Pamidronate—Leukopenia—Pravastatin—atherosclerosis	0.00192	0.00259	CcSEcCtD
Pamidronate—Loss of consciousness—Niacin—atherosclerosis	0.00191	0.00258	CcSEcCtD
Pamidronate—Cough—Niacin—atherosclerosis	0.0019	0.00256	CcSEcCtD
Pamidronate—Thrombocytopenia—Simvastatin—atherosclerosis	0.00189	0.00256	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00188	0.00254	CcSEcCtD
Pamidronate—Insomnia—Lovastatin—atherosclerosis	0.00187	0.00253	CcSEcCtD
Pamidronate—Cough—Pravastatin—atherosclerosis	0.00187	0.00253	CcSEcCtD
Pamidronate—FDPS—Metabolism—PLTP—atherosclerosis	0.00186	0.00766	CbGpPWpGaD
Pamidronate—Paraesthesia—Lovastatin—atherosclerosis	0.00186	0.00251	CcSEcCtD
Pamidronate—Arthralgia—Niacin—atherosclerosis	0.00185	0.0025	CcSEcCtD
Pamidronate—Myalgia—Niacin—atherosclerosis	0.00185	0.0025	CcSEcCtD
Pamidronate—Hypertension—Pravastatin—atherosclerosis	0.00185	0.0025	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00185	0.0025	CcSEcCtD
Pamidronate—Anorexia—Simvastatin—atherosclerosis	0.00184	0.00249	CcSEcCtD
Pamidronate—Dyspnoea—Lovastatin—atherosclerosis	0.00184	0.00249	CcSEcCtD
Pamidronate—Insomnia—Ezetimibe—atherosclerosis	0.00183	0.00248	CcSEcCtD
Pamidronate—Myalgia—Pravastatin—atherosclerosis	0.00182	0.00246	CcSEcCtD
Pamidronate—Arthralgia—Pravastatin—atherosclerosis	0.00182	0.00246	CcSEcCtD
Pamidronate—Paraesthesia—Ezetimibe—atherosclerosis	0.00182	0.00246	CcSEcCtD
Pamidronate—Dyspepsia—Lovastatin—atherosclerosis	0.00182	0.00246	CcSEcCtD
Pamidronate—Anxiety—Pravastatin—atherosclerosis	0.00182	0.00246	CcSEcCtD
Pamidronate—Dyspnoea—Ezetimibe—atherosclerosis	0.00181	0.00244	CcSEcCtD
Pamidronate—Discomfort—Pravastatin—atherosclerosis	0.0018	0.00243	CcSEcCtD
Pamidronate—Hypersensitivity—Rosuvastatin—atherosclerosis	0.0018	0.00243	CcSEcCtD
Pamidronate—Decreased appetite—Lovastatin—atherosclerosis	0.0018	0.00243	CcSEcCtD
Pamidronate—Dyspepsia—Ezetimibe—atherosclerosis	0.00178	0.00241	CcSEcCtD
Pamidronate—Fatigue—Lovastatin—atherosclerosis	0.00178	0.00241	CcSEcCtD
Pamidronate—Oedema—Niacin—atherosclerosis	0.00178	0.0024	CcSEcCtD
Pamidronate—Anaphylactic shock—Niacin—atherosclerosis	0.00178	0.0024	CcSEcCtD
Pamidronate—Constipation—Lovastatin—atherosclerosis	0.00177	0.00239	CcSEcCtD
Pamidronate—Pain—Lovastatin—atherosclerosis	0.00177	0.00239	CcSEcCtD
Pamidronate—Confusional state—Pravastatin—atherosclerosis	0.00176	0.00238	CcSEcCtD
Pamidronate—Decreased appetite—Ezetimibe—atherosclerosis	0.00176	0.00238	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00176	0.00238	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00175	0.00236	CcSEcCtD
Pamidronate—Asthenia—Rosuvastatin—atherosclerosis	0.00175	0.00236	CcSEcCtD
Pamidronate—Insomnia—Simvastatin—atherosclerosis	0.00175	0.00236	CcSEcCtD
Pamidronate—Oedema—Pravastatin—atherosclerosis	0.00175	0.00236	CcSEcCtD
Pamidronate—Anaphylactic shock—Pravastatin—atherosclerosis	0.00175	0.00236	CcSEcCtD
Pamidronate—Fatigue—Ezetimibe—atherosclerosis	0.00175	0.00236	CcSEcCtD
Pamidronate—Shock—Niacin—atherosclerosis	0.00175	0.00236	CcSEcCtD
Pamidronate—Infection—Pravastatin—atherosclerosis	0.00174	0.00235	CcSEcCtD
Pamidronate—Paraesthesia—Simvastatin—atherosclerosis	0.00174	0.00235	CcSEcCtD
Pamidronate—Pain—Ezetimibe—atherosclerosis	0.00173	0.00234	CcSEcCtD
Pamidronate—Constipation—Ezetimibe—atherosclerosis	0.00173	0.00234	CcSEcCtD
Pamidronate—Tachycardia—Niacin—atherosclerosis	0.00173	0.00234	CcSEcCtD
Pamidronate—Pruritus—Rosuvastatin—atherosclerosis	0.00173	0.00233	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.00172	0.0071	CbGpPWpGaD
Pamidronate—Dyspnoea—Simvastatin—atherosclerosis	0.00172	0.00233	CcSEcCtD
Pamidronate—Hyperhidrosis—Niacin—atherosclerosis	0.00172	0.00232	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.00171	0.00705	CbGpPWpGaD
Pamidronate—Thrombocytopenia—Pravastatin—atherosclerosis	0.00171	0.00231	CcSEcCtD
Pamidronate—Feeling abnormal—Lovastatin—atherosclerosis	0.0017	0.0023	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.0017	0.00701	CbGpPWpGaD
Pamidronate—Dyspepsia—Simvastatin—atherosclerosis	0.0017	0.0023	CcSEcCtD
Pamidronate—Anorexia—Niacin—atherosclerosis	0.00169	0.00229	CcSEcCtD
Pamidronate—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00169	0.00228	CcSEcCtD
Pamidronate—Hyperhidrosis—Pravastatin—atherosclerosis	0.00169	0.00228	CcSEcCtD
Pamidronate—Decreased appetite—Simvastatin—atherosclerosis	0.00168	0.00227	CcSEcCtD
Pamidronate—Feeling abnormal—Ezetimibe—atherosclerosis	0.00167	0.00226	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00167	0.00226	CcSEcCtD
Pamidronate—Diarrhoea—Rosuvastatin—atherosclerosis	0.00167	0.00225	CcSEcCtD
Pamidronate—Fatigue—Simvastatin—atherosclerosis	0.00167	0.00225	CcSEcCtD
Pamidronate—Anorexia—Pravastatin—atherosclerosis	0.00167	0.00225	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.00166	0.00685	CbGpPWpGaD
Pamidronate—Hypotension—Niacin—atherosclerosis	0.00166	0.00224	CcSEcCtD
Pamidronate—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00166	0.00224	CcSEcCtD
Pamidronate—Pain—Simvastatin—atherosclerosis	0.00165	0.00223	CcSEcCtD
Pamidronate—Constipation—Simvastatin—atherosclerosis	0.00165	0.00223	CcSEcCtD
Pamidronate—FDPS—SREBP signalling—AKT1—atherosclerosis	0.00164	0.00676	CbGpPWpGaD
Pamidronate—Abdominal pain—Lovastatin—atherosclerosis	0.00163	0.00221	CcSEcCtD
Pamidronate—Body temperature increased—Lovastatin—atherosclerosis	0.00163	0.00221	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00162	0.00219	CcSEcCtD
Pamidronate—FDPS—Metabolism—LTA4H—atherosclerosis	0.00161	0.00664	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ABCG8—atherosclerosis	0.00161	0.00664	CbGpPWpGaD
Pamidronate—Dizziness—Rosuvastatin—atherosclerosis	0.00161	0.00218	CcSEcCtD
Pamidronate—Insomnia—Niacin—atherosclerosis	0.00161	0.00217	CcSEcCtD
Pamidronate—Abdominal pain—Ezetimibe—atherosclerosis	0.0016	0.00217	CcSEcCtD
Pamidronate—Body temperature increased—Ezetimibe—atherosclerosis	0.0016	0.00217	CcSEcCtD
Pamidronate—Paraesthesia—Niacin—atherosclerosis	0.00159	0.00215	CcSEcCtD
Pamidronate—Feeling abnormal—Simvastatin—atherosclerosis	0.00159	0.00215	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.00159	0.00656	CbGpPWpGaD
Pamidronate—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00159	0.00215	CcSEcCtD
Pamidronate—Dyspnoea—Niacin—atherosclerosis	0.00158	0.00214	CcSEcCtD
Pamidronate—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00158	0.00214	CcSEcCtD
Pamidronate—Insomnia—Pravastatin—atherosclerosis	0.00158	0.00214	CcSEcCtD
Pamidronate—Somnolence—Niacin—atherosclerosis	0.00158	0.00213	CcSEcCtD
Pamidronate—Paraesthesia—Pravastatin—atherosclerosis	0.00157	0.00212	CcSEcCtD
Pamidronate—Dyspepsia—Niacin—atherosclerosis	0.00156	0.00211	CcSEcCtD
Pamidronate—Dyspnoea—Pravastatin—atherosclerosis	0.00156	0.00211	CcSEcCtD
Pamidronate—Decreased appetite—Niacin—atherosclerosis	0.00154	0.00209	CcSEcCtD
Pamidronate—Dyspepsia—Pravastatin—atherosclerosis	0.00154	0.00208	CcSEcCtD
Pamidronate—Rash—Rosuvastatin—atherosclerosis	0.00154	0.00208	CcSEcCtD
Pamidronate—Dermatitis—Rosuvastatin—atherosclerosis	0.00154	0.00208	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Niacin—atherosclerosis	0.00153	0.00207	CcSEcCtD
Pamidronate—Abdominal pain—Simvastatin—atherosclerosis	0.00153	0.00207	CcSEcCtD
Pamidronate—Body temperature increased—Simvastatin—atherosclerosis	0.00153	0.00207	CcSEcCtD
Pamidronate—Headache—Rosuvastatin—atherosclerosis	0.00153	0.00206	CcSEcCtD
Pamidronate—Hypersensitivity—Lovastatin—atherosclerosis	0.00152	0.00206	CcSEcCtD
Pamidronate—Decreased appetite—Pravastatin—atherosclerosis	0.00152	0.00205	CcSEcCtD
Pamidronate—Pain—Niacin—atherosclerosis	0.00152	0.00205	CcSEcCtD
Pamidronate—Fatigue—Pravastatin—atherosclerosis	0.00151	0.00204	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.0015	0.00619	CbGpPWpGaD
Pamidronate—Constipation—Pravastatin—atherosclerosis	0.00149	0.00202	CcSEcCtD
Pamidronate—Pain—Pravastatin—atherosclerosis	0.00149	0.00202	CcSEcCtD
Pamidronate—Hypersensitivity—Ezetimibe—atherosclerosis	0.00149	0.00202	CcSEcCtD
Pamidronate—Asthenia—Lovastatin—atherosclerosis	0.00148	0.002	CcSEcCtD
Pamidronate—Pruritus—Lovastatin—atherosclerosis	0.00146	0.00198	CcSEcCtD
Pamidronate—Asthenia—Ezetimibe—atherosclerosis	0.00145	0.00197	CcSEcCtD
Pamidronate—Gastrointestinal pain—Niacin—atherosclerosis	0.00145	0.00196	CcSEcCtD
Pamidronate—Nausea—Rosuvastatin—atherosclerosis	0.00145	0.00196	CcSEcCtD
Pamidronate—Feeling abnormal—Pravastatin—atherosclerosis	0.00144	0.00195	CcSEcCtD
Pamidronate—Pruritus—Ezetimibe—atherosclerosis	0.00143	0.00194	CcSEcCtD
Pamidronate—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00143	0.00193	CcSEcCtD
Pamidronate—Hypersensitivity—Simvastatin—atherosclerosis	0.00142	0.00192	CcSEcCtD
Pamidronate—Diarrhoea—Lovastatin—atherosclerosis	0.00141	0.00191	CcSEcCtD
Pamidronate—Abdominal pain—Niacin—atherosclerosis	0.0014	0.0019	CcSEcCtD
Pamidronate—Body temperature increased—Niacin—atherosclerosis	0.0014	0.0019	CcSEcCtD
Pamidronate—Asthenia—Simvastatin—atherosclerosis	0.00139	0.00187	CcSEcCtD
Pamidronate—Diarrhoea—Ezetimibe—atherosclerosis	0.00139	0.00187	CcSEcCtD
Pamidronate—Body temperature increased—Pravastatin—atherosclerosis	0.00138	0.00187	CcSEcCtD
Pamidronate—Abdominal pain—Pravastatin—atherosclerosis	0.00138	0.00187	CcSEcCtD
Pamidronate—Pruritus—Simvastatin—atherosclerosis	0.00137	0.00185	CcSEcCtD
Pamidronate—Dizziness—Lovastatin—atherosclerosis	0.00137	0.00185	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.00134	0.00552	CbGpPWpGaD
Pamidronate—Dizziness—Ezetimibe—atherosclerosis	0.00134	0.00181	CcSEcCtD
Pamidronate—Diarrhoea—Simvastatin—atherosclerosis	0.00132	0.00179	CcSEcCtD
Pamidronate—Vomiting—Lovastatin—atherosclerosis	0.00131	0.00178	CcSEcCtD
Pamidronate—Hypersensitivity—Niacin—atherosclerosis	0.00131	0.00177	CcSEcCtD
Pamidronate—Rash—Lovastatin—atherosclerosis	0.0013	0.00176	CcSEcCtD
Pamidronate—Dermatitis—Lovastatin—atherosclerosis	0.0013	0.00176	CcSEcCtD
Pamidronate—Headache—Lovastatin—atherosclerosis	0.00129	0.00175	CcSEcCtD
Pamidronate—Vomiting—Ezetimibe—atherosclerosis	0.00129	0.00174	CcSEcCtD
Pamidronate—Hypersensitivity—Pravastatin—atherosclerosis	0.00129	0.00174	CcSEcCtD
Pamidronate—Dizziness—Simvastatin—atherosclerosis	0.00128	0.00173	CcSEcCtD
Pamidronate—Rash—Ezetimibe—atherosclerosis	0.00128	0.00173	CcSEcCtD
Pamidronate—Dermatitis—Ezetimibe—atherosclerosis	0.00128	0.00173	CcSEcCtD
Pamidronate—FDPS—Metabolism—ABCG1—atherosclerosis	0.00128	0.00525	CbGpPWpGaD
Pamidronate—Asthenia—Niacin—atherosclerosis	0.00127	0.00172	CcSEcCtD
Pamidronate—Headache—Ezetimibe—atherosclerosis	0.00127	0.00172	CcSEcCtD
Pamidronate—Pruritus—Niacin—atherosclerosis	0.00126	0.0017	CcSEcCtD
Pamidronate—Asthenia—Pravastatin—atherosclerosis	0.00125	0.00169	CcSEcCtD
Pamidronate—Pruritus—Pravastatin—atherosclerosis	0.00124	0.00167	CcSEcCtD
Pamidronate—Vomiting—Simvastatin—atherosclerosis	0.00123	0.00166	CcSEcCtD
Pamidronate—Nausea—Lovastatin—atherosclerosis	0.00123	0.00166	CcSEcCtD
Pamidronate—Rash—Simvastatin—atherosclerosis	0.00122	0.00165	CcSEcCtD
Pamidronate—Dermatitis—Simvastatin—atherosclerosis	0.00122	0.00165	CcSEcCtD
Pamidronate—Diarrhoea—Niacin—atherosclerosis	0.00121	0.00164	CcSEcCtD
Pamidronate—Headache—Simvastatin—atherosclerosis	0.00121	0.00164	CcSEcCtD
Pamidronate—Nausea—Ezetimibe—atherosclerosis	0.0012	0.00163	CcSEcCtD
Pamidronate—FDPS—Metabolism—FABP4—atherosclerosis	0.0012	0.00494	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—LCAT—atherosclerosis	0.0012	0.00494	CbGpPWpGaD
Pamidronate—Diarrhoea—Pravastatin—atherosclerosis	0.0012	0.00162	CcSEcCtD
Pamidronate—FDPS—Metabolism—APOA4—atherosclerosis	0.00118	0.00484	CbGpPWpGaD
Pamidronate—Dizziness—Niacin—atherosclerosis	0.00117	0.00159	CcSEcCtD
Pamidronate—FDPS—Metabolism—CYP7A1—atherosclerosis	0.00116	0.00476	CbGpPWpGaD
Pamidronate—Dizziness—Pravastatin—atherosclerosis	0.00116	0.00156	CcSEcCtD
Pamidronate—Nausea—Simvastatin—atherosclerosis	0.00115	0.00155	CcSEcCtD
Pamidronate—Vomiting—Niacin—atherosclerosis	0.00113	0.00153	CcSEcCtD
Pamidronate—Rash—Niacin—atherosclerosis	0.00112	0.00151	CcSEcCtD
Pamidronate—Dermatitis—Niacin—atherosclerosis	0.00112	0.00151	CcSEcCtD
Pamidronate—Headache—Niacin—atherosclerosis	0.00111	0.0015	CcSEcCtD
Pamidronate—Vomiting—Pravastatin—atherosclerosis	0.00111	0.0015	CcSEcCtD
Pamidronate—Rash—Pravastatin—atherosclerosis	0.0011	0.00149	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.0011	0.00454	CbGpPWpGaD
Pamidronate—Dermatitis—Pravastatin—atherosclerosis	0.0011	0.00149	CcSEcCtD
Pamidronate—Headache—Pravastatin—atherosclerosis	0.00109	0.00148	CcSEcCtD
Pamidronate—FDPS—Metabolism—CYP27A1—atherosclerosis	0.00107	0.0044	CbGpPWpGaD
Pamidronate—Nausea—Niacin—atherosclerosis	0.00105	0.00142	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.00105	0.00433	CbGpPWpGaD
Pamidronate—Nausea—Pravastatin—atherosclerosis	0.00104	0.0014	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.00103	0.00423	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—APOA2—atherosclerosis	0.00101	0.00417	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PLA2G2A—atherosclerosis	0.00101	0.00417	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ALOX5AP—atherosclerosis	0.00101	0.00417	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ALOX15—atherosclerosis	0.00101	0.00417	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ABCG5—atherosclerosis	0.001	0.00412	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.001	0.00411	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—LPA—atherosclerosis	0.000967	0.00398	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—BGN—atherosclerosis	0.000936	0.00385	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.000929	0.00383	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—APOA5—atherosclerosis	0.000927	0.00381	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.0009	0.0037	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PLA2G1B—atherosclerosis	0.000892	0.00367	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000882	0.00363	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.000874	0.0036	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000872	0.00359	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ALOX5—atherosclerosis	0.000861	0.00355	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000796	0.00328	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—NAMPT—atherosclerosis	0.000773	0.00318	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.000768	0.00316	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—LIPC—atherosclerosis	0.000768	0.00316	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—APOC3—atherosclerosis	0.000763	0.00314	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—LDLR—atherosclerosis	0.000758	0.00312	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CETP—atherosclerosis	0.000741	0.00305	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—SCARB1—atherosclerosis	0.000709	0.00292	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000691	0.00284	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—HMGCR—atherosclerosis	0.00067	0.00276	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000604	0.00249	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ABCA1—atherosclerosis	0.000597	0.00246	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—HMOX1—atherosclerosis	0.000512	0.00211	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—APOB—atherosclerosis	0.000491	0.00202	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—GSTM1—atherosclerosis	0.000477	0.00196	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—LPL—atherosclerosis	0.000469	0.00193	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—GPX1—atherosclerosis	0.000457	0.00188	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CD36—atherosclerosis	0.000445	0.00183	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—MTHFR—atherosclerosis	0.000422	0.00174	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PPARA—atherosclerosis	0.000414	0.0017	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—AGT—atherosclerosis	0.000401	0.00165	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—APOE—atherosclerosis	0.000393	0.00162	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CAV1—atherosclerosis	0.000389	0.0016	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—APOA1—atherosclerosis	0.000388	0.0016	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PIK3CG—atherosclerosis	0.000354	0.00146	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PPARG—atherosclerosis	0.000342	0.00141	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—INS—atherosclerosis	0.000336	0.00138	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ALB—atherosclerosis	0.000308	0.00127	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—NOS3—atherosclerosis	0.000294	0.00121	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PTGS2—atherosclerosis	0.000269	0.00111	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—AKT1—atherosclerosis	0.000135	0.000557	CbGpPWpGaD
